Maravai LifeSciences Holdings, Inc. MRVI NASDAQ

Maravai LifeSciences Holdings, Inc. (MRVI) reported total assets of $770.58M and total liabilities of $397.87M for fiscal year 2025, resulting in total equity of $372.71M.

The company held $216.89M in cash and short-term investments. Total debt stood at $35.58M, with net debt of $-181.31M. The Debt-to-Equity (D/E) ratio was 0.1 (conservative).

Current ratio is 6.6, indicating strong short-term liquidity. Interest coverage is -0.2x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (21/100) — Total assets $770.58M and equity $372.71M support the company's competitive scale
• VALUE (97/100) — Debt-to-Equity 0.1 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.

ARGX

argenx SE

$828.35

+2.36%

INSM

Insmed Incorporated

$153.40

+1.50%

ROIV

Roivant Sciences Ltd.

$29.12

+0.59%

INCY

Incyte Corporation

$97.69

+2.24%

ASND

Ascendis Pharma A/S

$249.84

+0.52%

RXDX

Prometheus Biosciences, Inc.

$199.92

+0.09%

CERE

Cerevel Therapeutics Holdings, Inc.

$44.96

+0.74%

CYTK

Cytokinetics, Incorporated

$66.35

-0.55%